Rare Disease Clinical Trial Feasibility Tool
Rare Disease Management announced its rare disease clinical trial feasibility tool
Rare Disease Management (RDM)
, a clinical development company, based in Wilmington, NC focusing primarily on orphan and rare diseases, announced its rare disease clinical trial feasibility tool that enables pharmaceutical, biotech and CRO clients to best identify the top investigators in orphan and rare diseases. The tool— ExpertSense—was developed by RDM in collaboration with the Technical University of Denmark Bioinformatics team. That team was also responsible for the introduction of FindZebra, a investigator tool that helps give rare disease investigators a hypothesis for rare diseases.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Final ENLIVEN Trial Results Confirm Long-Term Benefit of Turalio in Tenosynovial Giant Cell Tumor
July 9th 2025In final data from the Phase III ENLIVEN study, Turalio (pexidartinib) demonstrated durable tumor responses and a consistent safety profile in patients with symptomatic TGCT not amenable to surgery.
